Dyne Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Dyne Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Dyne Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Dyne Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.9M | 229k | 12.65 |
| 2025-06-30 | $2.8M | 294k | 9.52 |
| 2025-03-31 | $1.7M | 158k | 10.46 |
| 2024-12-31 | $3.4M | 143k | 23.56 |
| 2024-09-30 | $4.8M | 134k | 35.92 |
| 2024-06-30 | $4.5M | 128k | 35.29 |
| 2024-03-31 | $888k | 31k | 28.39 |
| 2023-12-31 | $338k | 25k | 13.30 |
| 2023-09-30 | $110k | 12k | 8.96 |
| 2023-06-30 | $141k | 12k | 11.52 |
| 2023-03-31 | $141k | 12k | 11.52 |
| 2022-12-31 | $142k | 12k | 11.59 |
| 2022-09-30 | $155k | 12k | 12.70 |
| 2022-06-30 | $84k | 12k | 6.87 |
| 2022-03-31 | $118k | 12k | 9.64 |
| 2021-12-31 | $145k | 12k | 11.89 |
| 2021-09-30 | $199k | 12k | 16.24 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas